Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
US Department of Justice
Citi
Mallinckrodt
Moodys

Generated: July 16, 2019

DrugPatentWatch Database Preview

Patent: 9,505,841

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,505,841
Title:Use of an anti-Ang2 antibody
Abstract: A method of preventing or treating cancer using an anti-Ang2 antibody or an antigen-binding fragment thereof that specifically binds to an angiogenesis-inducing factor Angiopoietin-2 (Ang2) and complexes to a Tie2 receptor while bound with Ang2.
Inventor(s): Kim; Kyung Eun (Yongin-si, KR), Han; Sang Yeul (Yongin-si, KR), Koh; Gou Young (Daejeon, KR), Lee; Hyo Seon (Hwaseong-si, KR), Kim; Chan (Seoul, KR)
Assignee: SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR)
Application Number:14/446,199
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,505,841
Patent Claims:see list of patent claims

Details for Patent 9,505,841

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) ➤ Try a Free Trial RX search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18 ➤ Try a Free Trial SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) ➤ Try a Free Trial RX Orphan search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Try a Free Trial SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (Daejeon, KR) ➤ Try a Free Trial RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cipla
Johnson and Johnson
Teva
Moodys
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.